Jane V. Aldrich

2.1k total citations
84 papers, 1.7k citations indexed

About

Jane V. Aldrich is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Jane V. Aldrich has authored 84 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 64 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in Jane V. Aldrich's work include Neuropeptides and Animal Physiology (61 papers), Receptor Mechanisms and Signaling (50 papers) and Chemical Synthesis and Analysis (40 papers). Jane V. Aldrich is often cited by papers focused on Neuropeptides and Animal Physiology (61 papers), Receptor Mechanisms and Signaling (50 papers) and Chemical Synthesis and Analysis (40 papers). Jane V. Aldrich collaborates with scholars based in United States, Canada and Sweden. Jane V. Aldrich's co-authors include Jay P. McLaughlin, Thomas F. Murray, Kshitij A. Patkar, Gary E. DeLander, Nicolette C. Ross, Amanda N. Carey, Ellis Merlin, Barry Cherney, Wei‐Jie Fang and Shainnel O. Eans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Jane V. Aldrich

82 papers receiving 1.6k citations

Peers

Jane V. Aldrich

CMN

PHYSI

ONCOL

Shiv K. Sharma United States

Norman D. Boyd United States

Vivien A. Warren United States

Brice Campo Switzerland

Michel Hugues France

Regina D. Zeikus United States

B. Rouot France

Hitoshi Kakidani Japan

Kate Loughney United States

Xiaoxing Huang China

Shiv K. Sharma United States

Jane V. Aldrich

1.0k ×0.7

861 ×0.8

CMN

99 ×0.4

157 ×1.0

PHYSI

48 ×0.6

ONCOL

Citations per year, relative to Jane V. Aldrich Jane V. Aldrich (= 1×) peers Shiv K. Sharma

Countries citing papers authored by Jane V. Aldrich

Since Specialization

Citations

This map shows the geographic impact of Jane V. Aldrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane V. Aldrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane V. Aldrich more than expected).

Fields of papers citing papers by Jane V. Aldrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane V. Aldrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane V. Aldrich. The network helps show where Jane V. Aldrich may publish in the future.

Co-authorship network of co-authors of Jane V. Aldrich

This figure shows the co-authorship network connecting the top 25 collaborators of Jane V. Aldrich. A scholar is included among the top collaborators of Jane V. Aldrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane V. Aldrich. Jane V. Aldrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eans, Shainnel O., Jéssica Medina, Tanvir Khaliq, et al.. (2023). Tryptophan Substitution in CJ-15,208 (cyclo[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference. Pharmaceuticals. 16(9). 1218–1218. 2 indexed citations

Eans, Shainnel O., et al.. (2022). An analog of [d-Trp]CJ-15,208 exhibits kappa opioid receptor antagonism following oral administration and prevents stress-induced reinstatement of extinguished morphine conditioned place preference. Pharmacology Biochemistry and Behavior. 217. 173405–173405. 2 indexed citations

Aldrich, Jane V., et al.. (2021). Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay. Biomedicine & Pharmacotherapy. 143. 112173–112173. 1 indexed citations

Aldrich, Jane V. & Jay P. McLaughlin. (2021). Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development. Handbook of experimental pharmacology. 271. 197–220. 12 indexed citations

Huang, Peng, et al.. (2016). Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests. Neuroscience Letters. 615. 15–20. 14 indexed citations

Khaliq, Tanvir, et al.. (2016). Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study. Journal of Chromatography B. 1028. 11–15. 5 indexed citations

Sirohi, Sunil, Jane V. Aldrich, & Brendan M. Walker. (2016). Species differences in the effects of the κ-opioid receptor antagonist zyklophin. Alcohol. 51. 43–49. 6 indexed citations

Audus, Kenneth L., et al.. (2012). The permeation of dynorphin A 1–6 across the blood brain barrier and its effect on bovine brain microvessel endothelial cell monolayer permeability. Peptides. 38(2). 414–417. 5 indexed citations

Ross, Nicolette C., et al.. (2011). Novel opioid cyclic tetrapeptides: Trp isomers of CJ‐15,208 exhibit distinct opioid receptor agonism and short‐acting κ opioid receptor antagonism. British Journal of Pharmacology. 165(4b). 1097–1108. 48 indexed citations

10.

Fang, Wei‐Jie, T. V. Yakovleva, & Jane V. Aldrich. (2011). A convenient approach to synthesizing peptide C‐terminal N‐alkyl amides. Biopolymers. 96(6). 715–722. 10 indexed citations

11.

Ross, Nicolette C., Santosh S. Kulkarni, Jay P. McLaughlin, & Jane V. Aldrich. (2010). Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist. Tetrahedron Letters. 51(38). 5020–5023. 26 indexed citations

12.

Aldrich, Jane V. & Jay P. McLaughlin. (2009). Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development. The AAPS Journal. 11(2). 312–322. 102 indexed citations

13.

Kulkarni, Santosh S., Nicolette C. Ross, Jay P. McLaughlin, & Jane V. Aldrich. (2009). Synthesis of Cyclic Tetrapeptide CJ 15,208: A Novel Kappa Opioid Receptor Antagonist. Advances in experimental medicine and biology. 611. 269–270. 11 indexed citations

14.

Murray, Thomas F., et al.. (2009). The Synthesis of DAMGO-Based Potential Affinity Labels with High Mu Opioid Receptor Affinity and the Formation of Cyclic O-Alkyl Thiocarbamates. Advances in experimental medicine and biology. 611. 265–266.

15.

Choi, Hee Kyoung, Thomas F. Murray, & Jane V. Aldrich. (2003). Synthesis and evaluation of derivatives of leucine enkephalin as potential affinity labels for δ opioid receptors. Biopolymers. 71(5). 552–557. 4 indexed citations

16.

Vig, Balvinder S., Thomas F. Murray, & Jane V. Aldrich. (2003). Synthesis of novel basic head‐to‐side‐chain cyclic dynorphin A analogs: Strategies and side reactions. Biopolymers. 71(6). 620–637. 10 indexed citations

17.

Aldrich, Jane V., et al.. (2000). A solid‐phase synthetic strategy for the preparation of peptide‐based affinity labels: synthesis of dynorphin A analogs. Journal of Peptide Research. 56(2). 80–87. 19 indexed citations

18.

Arttamangkul, Seksiri, Thomas F. Murray, Gary E. DeLander, & Jane V. Aldrich. (1995). Synthesis and Opioid Activity of Conformationally Constrained Dynorphin A Analogs. 1. Conformational Constraint in the "Message" Sequence. Journal of Medicinal Chemistry. 38(13). 2410–2417. 27 indexed citations

19.

Heidt, Martin, et al.. (1992). Effect of modification of the basic residues of dynorphin A-(1-13) amide on opioid receptor selectivity and opioid activity. Journal of Medicinal Chemistry. 35(23). 4330–4333. 29 indexed citations

20.

Aldrich, Jane V. & Rachel E. Baker. (1970). Biological control of Fusarium roseum f. sp. dianthi by Bacillus subtilis. The Plant disease reporter. 54(5). 446–448. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact